news_6

Shionogi Announces In Vitro and Real-World Data Presented at ECCMID 2021 Demonstrating Activity of cefiderocol Against Critical Priority Gram-negative Bacterial Pathogens

In vitro activity of cefiderocol has been demonstrated against the most difficult-to-treat Gram-negative bacteria, including carbapenem-resistant isolates of Pseudomonas aeruginosa,...

news_6

KANZHUN ALERT: Bragar Eagel & Squire, P.C. Is Investigating Kanzhun, Ltd. on Behalf of Kanzhun Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kanzhun...